Dash Bio Raises $30M in Series A Funding to Develop Automated Bioanalysis Platform for Drug Discovery
产业动态
来源：AI Insider发布时间待核实
Insider Brief Dash Bio has raised $30 million in Series A funding to expand its automated bioanalysis laboratory and software platform, bringing its total capital raised to $47.5 million. Oak HC/FT led the round, with participation from existing investors Freestyle Capital and Swift Ventures.